ANDA 86866, held by Watson Labs. Chlorpropamide.
As of Nov 13, 2026, ANDA 86866 (Chlorpropamide), held by Watson Labs, was not approved, with 6 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpropamide250MG ยท tablet;oral | Chlorpropamide | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 20, 1986 | Supplement 10Manufacturing | Approved | None posted |
| Aug 20, 1986 | Supplement 9Manufacturing | Approved | None posted |
| Aug 20, 1986 | Supplement 8Manufacturing | Approved | None posted |
| Aug 20, 1986 | Supplement 7Manufacturing | Approved | None posted |
| Mar 6, 1986 | Supplement 6Manufacturing | Approved | None posted |
| Sep 19, 1985 | Supplement 1Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
